ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 047,46
0,38%
DAX
17 896,50
-0,14%
Brent Oil
83,28
-0,31%
Bitcoin
59 123,66
1,52%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BioRestorative Therapies Inc (BRTX)

  7. BioRestorative Therapies Inc (BRTX) Actualités

BRTX

BioRestorative Therapies (BRTX)

BioRestorative Therapies Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BRTX
DateHeureSourceTitreSymboleSociété
30/04/202422h15GlobeNewswire Inc.BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024NASDAQ:BRTXBioRestorative Therapies Inc
30/04/202413h30GlobeNewswire Inc.BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics TechnologyNASDAQ:BRTXBioRestorative Therapies Inc
16/04/202416h25AllPennyStocks.comBiotech Catches Major Premarket Bid Following FDA ClearanceNASDAQ:BRTXBioRestorative Therapies Inc
16/04/202413h45GlobeNewswire Inc.BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol AmendmentNASDAQ:BRTXBioRestorative Therapies Inc
08/04/202413h45GlobeNewswire Inc.BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc DiseaseNASDAQ:BRTXBioRestorative Therapies Inc
03/04/202422h38GlobeNewswire Inc.BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued WarrantsNASDAQ:BRTXBioRestorative Therapies Inc
01/04/202413h45GlobeNewswire Inc.BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-KNASDAQ:BRTXBioRestorative Therapies Inc
11/03/202421h15GlobeNewswire Inc.BioRestorative Therapies to Participate in the 36th Annual ROTH ConferenceNASDAQ:BRTXBioRestorative Therapies Inc
06/03/202422h34Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
15/02/202422h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
14/02/202419h44Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
08/02/202422h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
06/02/202414h05GlobeNewswire Inc.BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-MarketNASDAQ:BRTXBioRestorative Therapies Inc
05/02/202413h30GlobeNewswire Inc.BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc DiseaseNASDAQ:BRTXBioRestorative Therapies Inc
01/02/202413h30GlobeNewswire Inc.BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual MeetingNASDAQ:BRTXBioRestorative Therapies Inc
12/12/202315h15GlobeNewswire Inc.BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity ProgramNASDAQ:BRTXBioRestorative Therapies Inc
15/11/202322h14Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BRTXBioRestorative Therapies Inc
09/10/202318h10GlobeNewswire Inc.BioRestorative Therapies, Inc. to Participate at the ROTH MKM Healthcare Opportunities Conference October 12, 2023 in New York CityNASDAQ:BRTXBioRestorative Therapies Inc
12/09/202315h00GlobeNewswire Inc.BioRestorative Therapies Enters into Supply Agreement with Evolutionary BiologicsNASDAQ:BRTXBioRestorative Therapies Inc
08/09/202314h30GlobeNewswire Inc.BioRestorative Therapies Announces Activation of Northwell Health in the Company's Phase 2 Clinical Trial Targeting Chronic Lumbar Disc DiseaseNASDAQ:BRTXBioRestorative Therapies Inc
23/08/202323h03Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BRTXBioRestorative Therapies Inc
11/08/202322h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BRTXBioRestorative Therapies Inc
04/08/202322h04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BRTXBioRestorative Therapies Inc
11/07/202314h30GlobeNewswire Inc.BioRestorative Therapies Announces $2.1 Million Registered Direct OfferingNASDAQ:BRTXBioRestorative Therapies Inc
28/06/202313h00InvestorsHub NewsWireBioRestorative Therapies Receives Unanimous Recommendation from Data Safety Monitoring Board (DSMB) to Continue its Phase 2 Clinical Trial without any ChangesNASDAQ:BRTXBioRestorative Therapies Inc
16/06/202313h00GlobeNewswire Inc.BioRestorative Therapies, Inc. to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ETNASDAQ:BRTXBioRestorative Therapies Inc
12/06/202313h00GlobeNewswire Inc.BioRestorative Therapies Announces Key Milestone of Dosing Completion in Safety Cohort of Phase 2 Trial Targeting Chronic Lumbar Disc DiseaseNASDAQ:BRTXBioRestorative Therapies Inc
01/06/202315h15GlobeNewswire Inc.BioRestorative Therapies, Inc. to attend the Jefferies 2023 Healthcare ConferenceNASDAQ:BRTXBioRestorative Therapies Inc
31/05/202313h00GlobeNewswire Inc.BioRestorative Therapies Receives License from New York State Department of Health to act as Tissue Bank for Mesenchymal Stem Cell ProcessingNASDAQ:BRTXBioRestorative Therapies Inc
15/05/202323h28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:BRTXBioRestorative Therapies Inc
 Showing the most relevant articles for your search:NASDAQ:BRTX

Dernières Valeurs Consultées

EU
BNP
BNP Paribas
COIN
ETHUSD
Ethereum
EU
ORA
Orange
EU
EN
Bouygues
EU
ML
Michelin
FTSE
UKX
FTSE 100
EU
SGO
Cie de SaintGobain
NASDAQ
NVDA
NVIDIA
EU
AI
Air Liquide
EU
DG
Vinci
COIN
BTCUSD
Bitcoin
NYSE
MRK
Merck
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés